Evidence map›Paper›PMID 24093440›Full record

ArticleJournal of proteome research2013

Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics.

Harsha P Gunawardena, Meghan E Feltcher, John A Wrobel, Sheng Gu, Miriam Braunstein, Xian Chen

Abstract readComparative Study
In one paragraph

Article in Journal of proteome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in molecular biosciences · 2022
    Article
  5. Article
  6. Accurate Identification of Closely RelatedFrontiers in cellular and infection microbiology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Proteomics progresses in microbial physiology and clinical antimicrobial therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Harsha P GunawardenaDepartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill , 120 Mason Farm Road, Campus Box 7260 3rd Floor, Genetic Medicine Building, Chapel Hill, North Carolina 27599, United States.
Meghan E Feltcher
John A Wrobel
Sheng Gu
Miriam Braunstein
Xian Chen
University of North Carolina at Chapel Hill · US

Funding

Proteomics Pathway DiscoveryU19AI109965 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2014 to 2018
$14.9M
Cancer Proteome Center at Washington Univ, Univ of North Carolina & Boise StateU24CA160035 · NCI · WASHINGTON UNIVERSITY · PI CHEN, XIAN, ELLIS, MATTHEW J · 2011 to 2016
$11.8M
Protein Secretion Pathways of Mycobacterium tuberculosisR01AI054540 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BRAUNSTEIN, MIRIAM S. · 2004 to 2013
$2.7M
Generating and Managing Large Scale Proteogenomic Data for ENCODE Cell LinesRC2HG005591 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHEN, XIAN, GIDDINGS, MORGAN CORINNE · 2009 to 2010
$1.6M
NCI NIH HHS U24 CA160035NHGRI NIH HHS RC2 HG005591NIAID NIH HHS AI054540NIAID NIH HHS R01 AI054540NIAID NIH HHS U19 AI109965PHS HHS 1R01A1064806
6 · The paper itself

Abstract

The Mycobacterium tuberculosis membrane is rich in antigens that are potential targets for diagnostics and the development of new vaccines. To better understand the mechanisms underlying MTB virulence and identify new targets for therapeutic intervention, we investigated the differential composition of membrane proteomes between virulent M. tuberculosis H37Rv (MTB) and the Mycobacterium bovis BCG vaccine strain. To compare the membrane proteomes, we used LC-MS/MS analysis in combination with label-free quantitative proteomics, utilizing the area under the curve of the extracted ion chromatograms of peptides obtained from m/z and retention time alignment of MS1 features. With this approach, we obtained relative abundance ratios for 2203 identified membrane-associated proteins in high confidence. Of these proteins, 294 showed statistically significant differences of at least two fold in relative abundance between MTB and BCG membrane fractions. Our comparative analysis detected several proteins associated with known genomic regions of difference between MTB and BCG as being absent, which validated the accuracy of our approach. In further support of our label-free quantitative data, we verified select protein differences by immunoblotting. To our knowledge, we have generated the first comprehensive and high-coverage profile of comparative membrane proteome changes between virulent MTB and its attenuated relative BCG, which helps elucidate the proteomic basis of the intrinsic virulence of the MTB pathogen.

Indexed as

Gene Expression Regulation, BacterialBacterial ProteinsCell MembraneChromatography, LiquidGenetic LociImmunoblottingMembrane ProteinsMolecular Sequence AnnotationMycobacterium bovisMycobacterium tuberculosisPeptidesProteolysisProteomeProteomicsTandem Mass SpectrometryTrypsinBacterial ProteinsMembrane ProteinsPeptidesProteomeTrypsin

Identifiers

PMID24093440
PMCPMC4360911
OpenAlexW2094364309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.